Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC

BSE8536.50-80.3 (-0.93 %)

PREV CLOSE ( ) 8616.80

OPEN PRICE ( ) 8623.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1314

TODAY'S LOW / HIGH ( )8467.85 8739.15

52 WK LOW / HIGH ( )5410.4 9370.35

NSE8538.75-85.5 (-0.99 %)

PREV CLOSE( ) 8624.25

OPEN PRICE ( ) 8535.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 18872

TODAY'S LOW / HIGH( ) 8470.00 8851.00

52 WK LOW / HIGH ( )5415 9380

Select year

Particulars

Dec 2023

Dec 2004

Dec 2003

Operational & Financial Ratios

Earnings Per Share (Rs)

262.13

67.71

45.41

CEPS(Rs)

279.35

75.86

53.69

DPS(Rs)

167.00

16.00

Book NAV/Share(Rs)

411.70

189.40

142.30

Tax Rate(%)

28.69

34.75

32.85

Margin Ratios

Core EBITDA Margin(%)

27.07

28.98

21.62

EBIT Margin(%)

28.58

29.96

21.93

Pre Tax Margin(%)

28.52

29.94

21.90

PAT Margin (%)

20.34

19.54

14.71

Cash Profit Margin (%)

21.68

21.89

17.39

Performance Ratios

ROA(%)

22.71

28.32

21.10

ROE(%)

87.18

40.83

31.91

ROCE(%)

115.15

59.81

45.43

Asset Turnover(x)

1.12

1.45

1.43

Sales/Fixed Asset(x)

6.97

2.75

2.53

Working Capital/Sales(x)

4.97

2.62

3.90

Efficiency Ratios

Fixed Capital/Sales(x)

0.14

0.36

0.40

Receivable days

13.83

31.95

24.03

Inventory Days

47.71

47.19

48.91

Payable days

50.43

47.00

48.21

Valuation Parameters

PER(x)

30.78

19.51

15.34

PCE(x)

28.88

17.41

12.97

Price/Book(x)

19.59

6.97

4.89

Yield(%)

2.07

1.21

2.30

EV/Net Sales(x)

6.37

3.88

2.26

EV/Core EBITDA(x)

20.88

11.48

8.83

EV/EBIT(x)

21.42

12.05

9.52

EV/CE(x)

17.88

4.76

3.00

M Cap / Sales

6.51

4.10

2.44

Growth Ratio

Net Sales Growth(%)

283.87

13.11

0.00

Core EBITDA Growth(%)

246.13

49.36

0.00

EBIT Growth(%)

254.32

53.30

0.00

PAT Growth(%)

286.60

49.13

0.00

EPS Growth(%)

287.11

49.13

0.00

Financial Stability Ratios

Total Debt/Equity(x)

0.00

0.05

Current Ratio(x)

1.24

3.33

2.37

Quick Ratio(x)

0.97

2.48

1.65

Interest Cover(x)

498.35

2369.71

654.26

Total Debt/Mcap(x)

0.00

0.01